Silence Therapeutics (SLN) Cost of Revenue (2024 - 2026)
Silence Therapeutics (SLN) reported Cost of Revenue of $11000.0 for Q1 2026, down 79.63% on a YoY basis from $54000.0 in Q1 2025, and down 8.33% sequentially from $12000.0 in Q4 2025.
Silence Therapeutics (SLN) Cost of Revenue (2024 - 2026) Analysis & Trends
Silence Therapeutics (SLN) has 3 years of Cost of Revenue data on file, last reported at $11000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cost of Revenue fell 79.63% year-over-year to $11000.0; the trailing twelve-month figure through Mar 2026 stood at $172000.0 (down 98.1% YoY), and the FY2025 full-year result was $215000.0, down 98.18% from the prior year.
- Cost of Revenue declined to $11000.0 in Q1 2026, from $12000.0 in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $3.6 million in Q3 2024 to a low of $11000.0 in Q1 2026.
- A 3-year average of $1.3 million and a median of $85000.0 in 2025 frame the typical range for Cost of Revenue.
- Across the five-year window, Cost of Revenue slumped 99.41% in 2025 and plunged 79.63% in 2026, its largest moves.
- Tracing SLN's Cost of Revenue over 3 years: stood at $2.0 million in 2024, then tumbled by 99.41% to $12000.0 in 2025, then slipped by 8.33% to $11000.0 in 2026.
- Business Quant data shows SLN's Cost of Revenue at $11000.0 in Q1 2026, $12000.0 in Q4 2025, and $64000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 167.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 392.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 296.00 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 145.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Silence Therapeutics | 1.70 Bn | 1.56 Bn | 411,000.00 | 11,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11,000.00 |
| Mar 31, 2026 | 11,000.00 |
| Dec 31, 2025 | 12,000.00 |
| Dec 31, 2025 | 12,000.00 |
| Sep 30, 2025 | 64,000.00 |
| Sep 30, 2025 | 64,000.00 |
| Jun 30, 2025 | 85,000.00 |
| Jun 30, 2025 | 85,000.00 |
| Mar 31, 2025 | 54,000.00 |
| Mar 31, 2025 | 54,000.00 |
| Dec 31, 2024 | 2.04 Mn |
| Dec 31, 2024 | 2.04 Mn |
| Sep 30, 2024 | 3.64 Mn |
| Sep 30, 2024 | 3.64 Mn |
| Jun 30, 2024 | 3.33 Mn |
| Jun 30, 2024 | 3.33 Mn |
| Mar 31, 2024 | 2.80 Mn |
| Mar 31, 2024 | 2.80 Mn |